IDiyas

For the Inventor, By the Inventor

Lyons, France

Bruno Guy

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 95(Granted Patents)


Company Filing History:

goldMedal5 out of 162 
 
Sanofi Pasteur Inc.
 patents
silverMedal4 out of 47 
 
Sanofi Pasteur Sa
 patents
bronzeMedal4 out of 26 
 
Centers for Disease Control and Prevention
 patents
4. 3 out of 145 
 
Connaught Laboratories Limited
 patents
5. 2 out of 4 
 
Center for Disease Control and Prevention
 patents
6. 1 out of 6 
 
Pasteur Merieux Serums & Vaccins
 patents
7. 1 out of 13 
 
Acambis Inc.
 patents
8. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2018

Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 9937252 - Induction of cross-reactive cellular response against rhinovirus antigens (2018-04-10),
2. 9169298 - Dengue serotype 1 attenuated strain (2015-10-27),
3. 8795688 - Dengue serotype 2 attenuated strain (2014-08-05),
4. 8506971 - Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria (2013-08-13),
5. 8067566 - Dengue serotype 2 attenuated strain (2011-11-29),
6. 8067565 - Dengue serotype 1 attenuated strain (2011-11-29),
7. 7718359 - Method of immunization against the 4 serotypes of dengue fever (2010-05-18),
8. 7718358 - Method of immunization against the 4 dengue serotypes (2010-05-18),
9. 7718357 - Method of immunization against the 4 dengue serotypes (2010-05-18),
10. 7641908 - Dengue serotype 2 attenuated strain (2010-01-05),
11. 7641907 - Dengue serotype 1 attenuated strain (2010-01-05),
12. 7235243 - Immunological combination compositions and methods (2007-06-26),
13. 6984385 - Immunological combination compositions and methods (2006-01-10),
14. 6576244 - LT and CT in parenteral immunization methods against helicobacter infection (2003-06-10),
15. 6379675 - Immunological combination compositions and methods (2002-04-30),

Title: The Innovative Contributions of Bruno Guy

Introduction

Bruno Guy is a prominent inventor based in Lyons, France, known for his significant contributions to the field of biomedical research. With a total of 16 patents to his name, he has made remarkable advancements in the understanding and treatment of viral infections.

Latest Patents

Among his latest patents is the invention concerning the induction of cross-reactive cellular response against rhinovirus antigens. This invention involves an isolated peptide that is at least 90% identical to the VP4 amino acid sequence of a rhinovirus, along with an isolated polynucleotide encoding said peptide. Additionally, he has developed a vaccine composition that includes a live attenuated strain of Dengue serotype 1, derived from the wild-type dengue-1 strain 16007. This innovative approach aims to enhance the efficacy of vaccines against these viral infections.

Career Highlights

Bruno Guy has had a distinguished career, working with notable companies such as Sanofi Pasteur Inc. and Sanofi Pasteur S.A. His work has been instrumental in advancing vaccine development and improving public health outcomes.

Collaborations

Throughout his career, Bruno has collaborated with esteemed colleagues, including Jean Lang and Véronique Barban. These partnerships have fostered a collaborative environment that has led to groundbreaking research and innovations.

Conclusion

Bruno Guy's contributions to the field of biomedical research and his innovative patents highlight his role as a leading inventor in the industry. His work continues to impact the development of effective treatments and vaccines for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…